Biotech · Private company
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Track this companyFree. Adds Alpine Immune Sciences Inc, A Subsidiary of Vertex to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- PovetaciceptPhase 3 · Immunoglobulin A NephropathyClinicalTrials.gov · fetched Nov 12, 2026
- ALPN-101Phase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- PovetaciceptPhase 2 · Idiopathic Thrombocytopenic PurpuraClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)PHASE3 · ACTIVE_NOT_RECRUITING · started Aug 30, 2024ClinicalTrials.gov NCT06564142 · fetched Nov 12, 2026
- An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4)PHASE1_PHASE2 · COMPLETED · started Jul 3, 2023ClinicalTrials.gov NCT05757570 · fetched Nov 12, 2026
- ALPN-101 (Acazicolcept) in Systemic Lupus ErythematosusPHASE2 · COMPLETED · started Jun 22, 2021ClinicalTrials.gov NCT04835441 · fetched Nov 12, 2026